-
Je něco špatně v tomto záznamu ?
SGIP1 Deletion in Mice Attenuates Mechanical Hypersensitivity Elicited by Inflammation
O. Durydivka, M. Kuchar, J. Blahos
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
PubMed
38979622
DOI
10.1089/can.2024.0020
Knihovny.cz E-zdroje
- MeSH
- benzoxaziny * farmakologie MeSH
- hyperalgezie * genetika MeSH
- morfoliny farmakologie MeSH
- myši inbrední C57BL MeSH
- myši knockoutované * MeSH
- myši MeSH
- naftaleny MeSH
- nocicepce účinky léků MeSH
- receptor kanabinoidní CB1 * genetika metabolismus MeSH
- tetrahydrokanabinol * farmakologie MeSH
- zánět * MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Background: Activation of cannabinoid receptor 1 (CB1R) in the nervous system modulates the processing of acute and chronic pain. CB1R activity is regulated by desensitization and internalization. SH3-containing GRB2-like protein 3-interacting protein 1 (SGIP1) inhibits the internalization of CB1R. This causes increased and prolonged association of the desensitized receptor with G protein-coupled receptor kinase 3 (GRK3) and beta-arrestin on the cell membrane and results in decreased activation of extracellular signal-regulated kinase 1/2 (ERK1/2) pathway. Genetic deletion of SGIP1 in mice leads to altered CB1R-related functions, such as decreased anxiety-like behaviors, modified cannabinoid tetrad behaviors, reduced acute nociception, and increased sensitivity to analgesics. In this work, we asked if deletion of SGIP1 affects chronic nociception and analgesic effect of Δ9-tetrahydrocannabinol (THC) and WIN 55,212-2 (WIN) in mice. Methods: We measured tactile responses of hind paws to increasing pressure in wild-type and SGIP1 knock-out mice. Inflammation in the paw was induced by local injection of carrageenan. To determine the mechanical sensitivity, the paw withdrawal threshold (PWT) was measured using an electronic von Frey instrument with the progression of the applied force. Results: The responses to mechanical stimuli varied depending on the sex, genotype, and treatment. SGIP1 knock-out male mice exhibited lower PWT than wild-type males. On the contrary, the female mice exhibited comparable PWT. Following THC or WIN treatment in male mice, SGIP1 knock-out males exhibited PWT lower than wild-type males. THC treatment in SGIP1 knock-out females resulted in PWT higher than after THC treatment of wild-type females. However, SGIP1 knock-out and wild-type female mice exhibited similar PWT after WIN treatment. Conclusions: We provide evidence that SGIP1, possibly by interacting with CB1R, is involved in processing the responses to chronic pain. The absence of SGIP1 results in enhanced sensitivity to mechanical stimuli in males, but not females. The antinociceptive effect of THC is superior to that of WIN in SGIP1 knock-out mice in the carrageenan-induced model of chronic pain.
Institute of Molecular Genetics of the Czech Academy of Sciences Prague Czech Republic
Psychedelic Research Center National Institute of Mental Health Klecany Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009404
- 003
- CZ-PrNML
- 005
- 20250429135535.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/can.2024.0020 $2 doi
- 035 __
- $a (PubMed)38979622
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Durydivka, Oleh $u Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000192064092
- 245 10
- $a SGIP1 Deletion in Mice Attenuates Mechanical Hypersensitivity Elicited by Inflammation / $c O. Durydivka, M. Kuchar, J. Blahos
- 520 9_
- $a Background: Activation of cannabinoid receptor 1 (CB1R) in the nervous system modulates the processing of acute and chronic pain. CB1R activity is regulated by desensitization and internalization. SH3-containing GRB2-like protein 3-interacting protein 1 (SGIP1) inhibits the internalization of CB1R. This causes increased and prolonged association of the desensitized receptor with G protein-coupled receptor kinase 3 (GRK3) and beta-arrestin on the cell membrane and results in decreased activation of extracellular signal-regulated kinase 1/2 (ERK1/2) pathway. Genetic deletion of SGIP1 in mice leads to altered CB1R-related functions, such as decreased anxiety-like behaviors, modified cannabinoid tetrad behaviors, reduced acute nociception, and increased sensitivity to analgesics. In this work, we asked if deletion of SGIP1 affects chronic nociception and analgesic effect of Δ9-tetrahydrocannabinol (THC) and WIN 55,212-2 (WIN) in mice. Methods: We measured tactile responses of hind paws to increasing pressure in wild-type and SGIP1 knock-out mice. Inflammation in the paw was induced by local injection of carrageenan. To determine the mechanical sensitivity, the paw withdrawal threshold (PWT) was measured using an electronic von Frey instrument with the progression of the applied force. Results: The responses to mechanical stimuli varied depending on the sex, genotype, and treatment. SGIP1 knock-out male mice exhibited lower PWT than wild-type males. On the contrary, the female mice exhibited comparable PWT. Following THC or WIN treatment in male mice, SGIP1 knock-out males exhibited PWT lower than wild-type males. THC treatment in SGIP1 knock-out females resulted in PWT higher than after THC treatment of wild-type females. However, SGIP1 knock-out and wild-type female mice exhibited similar PWT after WIN treatment. Conclusions: We provide evidence that SGIP1, possibly by interacting with CB1R, is involved in processing the responses to chronic pain. The absence of SGIP1 results in enhanced sensitivity to mechanical stimuli in males, but not females. The antinociceptive effect of THC is superior to that of WIN in SGIP1 knock-out mice in the carrageenan-induced model of chronic pain.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a zánět $7 D007249
- 650 _2
- $a myši $7 D051379
- 650 12
- $a tetrahydrokanabinol $x farmakologie $7 D013759
- 650 12
- $a hyperalgezie $x genetika $7 D006930
- 650 12
- $a benzoxaziny $x farmakologie $7 D048588
- 650 12
- $a receptor kanabinoidní CB1 $x genetika $x metabolismus $7 D043884
- 650 12
- $a myši knockoutované $7 D018345
- 650 _2
- $a morfoliny $x farmakologie $7 D009025
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a nocicepce $x účinky léků $7 D059225
- 650 _2
- $a naftaleny $7 D009281
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kuchar, Martin $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Forensic Laboratory of Biologically Active Substances, Prague, Czech Republic $u Psychedelic Research Center, National Institute of Mental Health, Klecany, Czech Republic $1 https://orcid.org/0000000276166352 $7 xx0070908
- 700 1_
- $a Blahos, Jaroslav $u Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000198030061 $7 xx0179439
- 773 0_
- $w MED00209151 $t Cannabis and cannabinoid research $x 2378-8763 $g Roč. 10, č. 2 (2025), s. 247-257
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38979622 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135530 $b ABA008
- 999 __
- $a ok $b bmc $g 2311032 $s 1246485
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 10 $c 2 $d 247-257 $e 20240709 $i 2378-8763 $m Cannabis and cannabinoid research $n Cannabis Cannabinoid Res $x MED00209151
- LZP __
- $a Pubmed-20250415